Historically, surgery has been the most effective treatment for patients with early-stage non-small cell lung cancer (NSCLC). While technological improvements, such as the development of minimally invasive techniques (such as video-assisted thoracoscopic surgery or VATS), have made surgeries safer for patients, the ability to cure early-stage NSCLC patients hasn’t improved significantly in recent decades.
By Juhi Kunde, MA, LUNGevity Science Writer, December 14, 2021
In recent years, biomarker testing has grown increasingly more important and more complex as researchers understand critical details about the molecular basis of lung cancer. By testing the genomic make-up of each individual’s lung cancer, oncologists are better equipped to recommend treatment plans that are optimized for patient outcomes.
In the spring of 2021, Myra’s husband Kelvin had COVID-19. After, he had a lingering cough and shortness of breath. His chest hurt a bit when he breathed. They assumed it was pneumonia or at least COVID-related. They never guessed it would be lung cancer.
By Dr. Amy C. Moore, VP, Global Engagement and Patient Partnerships, December 6, 2021
By now, you have probably heard the news that scientists have discovered a new variant of the virus that causes COVID-19. This one is called omicron, a letter in the Greek alphabet, and joins the family of other SARS-CoV-2 variants including alpha, beta, gamma, delta, lamba, and mu.
Share Your Story
Submit your story, blog idea, or lung cancer-specific article on the many issues people affected by lung cancer face
Nominate someone living with lung cancer or a caregiver, volunteer, or fundraiser who is making a positive impact in the LUNGevity community.
Ask Nutrition Questions
Your questions may be answered in an upcoming Savor Health blog post!